Michele Mayo

Antibody-Maytansinoid Conjugates Designed to Bypass Multidrug Resistance

Yelena Kovtun, Charlene A. Audette, Michele Mayo et al. · Cancer Research · 2010 · 254 citations

Immunology, Immunotherapy, Tumor Biology +18

Tumor Delivery and In Vivo Processing of Disulfide-Linked and Thioether-Linked Antibody−Maytansinoid Conjugates

Hans K. Erickson, Wayne C. Widdison, Michele Mayo et al. · Bioconjugate Chemistry · 2009 · 238 citations

Engineering, Immunology, Immunotherapeutics +19

Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCL

Tabea Erdmann, Pavel Klener, James T. Lynch et al. · Blood · 2017 · 103 citations · Full text

A New Class of Antibody–Drug Conjugates with Potent DNA Alkylating Activity

Michael L. Miller, Nathan Fishkin, Wěi Li et al. · Molecular Cancer Therapeutics · 2016 · 100 citations

Tumor-selective Delivery, Tumor Biology, Medicinal Chemistry +16

Design of Antibody−Maytansinoid Conjugates Allows for Efficient Detoxification via Liver Metabolism

Xiuxia Sun, Wayne C. Widdison, Michele Mayo et al. · Bioconjugate Chemistry · 2011 · 94 citations

Pharmaceutical Science, Engineering, Immunology +22